These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15984537

  • 1. [Tumor markers in malignant lymphoma].
    Kato H, Ogura M.
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [Abstract] [Full Text] [Related]

  • 2. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N, Tsurumi H, Takemura M, Hara T, Sawada M, Kasahara S, Kanemura N, Yamada T, Shimizu M, Takahashi T, Tomita E, Seishima M, Takami T, Moriwaki H.
    Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 4. [Clinically relevant prognostic factors in malignant lymphoma].
    Engelhard M, Löffler M.
    Internist (Berl); 1993 Feb; 34(2):127-31. PubMed ID: 8454425
    [No Abstract] [Full Text] [Related]

  • 5. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M, Vose JM, Johnson MM, Do KA, Day A, Jilani I, Kantarjian H, Keating M, O'Brien SM, Verstovsek S, Armitage JO, Giles FJ.
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [Abstract] [Full Text] [Related]

  • 6. [Tumor markers in malignant lymphoma].
    Banno S, Ueda R.
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):149-53. PubMed ID: 11816473
    [Abstract] [Full Text] [Related]

  • 7. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M, Bello JL, Bendaña A, Rabuñal MJ, González S, Abuín I, Noya M, Cadarso C.
    Med Clin (Barc); 1998 Jul 11; 111(5):161-7. PubMed ID: 9732831
    [Abstract] [Full Text] [Related]

  • 8. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E, Balcerska A.
    Scand J Immunol; 2009 Nov 11; 70(5):490-500. PubMed ID: 19874554
    [Abstract] [Full Text] [Related]

  • 9. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A, Boycov O, Strenov Y, Okon E, Shpilberg O, Bairey O.
    Am J Hematol; 2009 Jun 11; 84(6):338-43. PubMed ID: 19384938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].
    Bettini R, Caronni F, Maino C, Marzetta K, Sala D, Saccà V, Gorini M.
    Recenti Prog Med; 2003 Nov 11; 94(11):494-500. PubMed ID: 14679917
    [Abstract] [Full Text] [Related]

  • 12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 11; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 13. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT, Bukaeva IA, Probatova NA, Smirnova EA, Tupitsyn NN, Sholokhova EN.
    Arkh Patol; 1996 Aug 11; 58(4):22-8. PubMed ID: 8967858
    [Abstract] [Full Text] [Related]

  • 14. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D, Hua TD, von Bonin F, Schoof N, Zeynalova S, Klöss M, Gocht D, Potthoff B, Tzvetkov M, Brockmöller J, Löffler M, Pfreundschuh M, Trümper L.
    Clin Cancer Res; 2008 Jun 15; 14(12):3777-84. PubMed ID: 18559596
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.
    Sadek I, Greer W, Foyle A.
    Clin Invest Med; 2000 Dec 15; 23(6):366-75. PubMed ID: 11152404
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.